Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States

On April 13, 2021, U.S. authorities announced an investigation into potential adverse events associated with the Johnson & Johnson (Janssen, J&J) COVID-19 vaccine and recommended “a pause in the use of this vaccine out of an abundance of caution.” We examined whether public attitudes toward...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Yuli Lily, Rak, Summer, SteelFisher, Gillian K, Bauhoff, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664657/
https://www.ncbi.nlm.nih.gov/pubmed/34903374
http://dx.doi.org/10.1016/j.vaccine.2021.11.085
_version_ 1784613888379060224
author Hsieh, Yuli Lily
Rak, Summer
SteelFisher, Gillian K
Bauhoff, Sebastian
author_facet Hsieh, Yuli Lily
Rak, Summer
SteelFisher, Gillian K
Bauhoff, Sebastian
author_sort Hsieh, Yuli Lily
collection PubMed
description On April 13, 2021, U.S. authorities announced an investigation into potential adverse events associated with the Johnson & Johnson (Janssen, J&J) COVID-19 vaccine and recommended “a pause in the use of this vaccine out of an abundance of caution.” We examined whether public attitudes toward COVID-19 vaccination shifted after this recommended suspension using an interrupted time series with data from the Census Bureau’s Household Pulse Survey, which was fielded bi-weekly between January 6 and April 26, 2021. We found no significant changes in trends of the proportion of the U.S. adult population hesitant about getting a COVID-19 vaccine, but a significant increase in concerns about safety and efficacy of COVID-19 vaccines among the already hesitant population.
format Online
Article
Text
id pubmed-8664657
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-86646572021-12-14 Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States Hsieh, Yuli Lily Rak, Summer SteelFisher, Gillian K Bauhoff, Sebastian Vaccine Short Communication On April 13, 2021, U.S. authorities announced an investigation into potential adverse events associated with the Johnson & Johnson (Janssen, J&J) COVID-19 vaccine and recommended “a pause in the use of this vaccine out of an abundance of caution.” We examined whether public attitudes toward COVID-19 vaccination shifted after this recommended suspension using an interrupted time series with data from the Census Bureau’s Household Pulse Survey, which was fielded bi-weekly between January 6 and April 26, 2021. We found no significant changes in trends of the proportion of the U.S. adult population hesitant about getting a COVID-19 vaccine, but a significant increase in concerns about safety and efficacy of COVID-19 vaccines among the already hesitant population. Elsevier Ltd. 2022-01-24 2021-12-11 /pmc/articles/PMC8664657/ /pubmed/34903374 http://dx.doi.org/10.1016/j.vaccine.2021.11.085 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Hsieh, Yuli Lily
Rak, Summer
SteelFisher, Gillian K
Bauhoff, Sebastian
Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States
title Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States
title_full Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States
title_fullStr Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States
title_full_unstemmed Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States
title_short Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States
title_sort effect of the suspension of the j&j covid-19 vaccine on vaccine hesitancy in the united states
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664657/
https://www.ncbi.nlm.nih.gov/pubmed/34903374
http://dx.doi.org/10.1016/j.vaccine.2021.11.085
work_keys_str_mv AT hsiehyulilily effectofthesuspensionofthejjcovid19vaccineonvaccinehesitancyintheunitedstates
AT raksummer effectofthesuspensionofthejjcovid19vaccineonvaccinehesitancyintheunitedstates
AT steelfishergilliank effectofthesuspensionofthejjcovid19vaccineonvaccinehesitancyintheunitedstates
AT bauhoffsebastian effectofthesuspensionofthejjcovid19vaccineonvaccinehesitancyintheunitedstates

Ejemplares similares